Pheochromocytoma is a rare but life-threatening condition due to catecholamine release induced by drug treatments such as β-blockers or glucocorticoids. We present a case of hypertensive crisis due to pheochromocytoma, induced after the initiation of dexamethasone and landiolol during intensive care for severe coronavirus disease 2019 (COVID-19). Based on a detailed medical history review, the patient was previously diagnosed with primary aldosteronism by confirmatory tests, moreover, an abdominal computed tomography scan identified an adrenal tumor 2 years before current admission. We tentatively diagnosed the patient with pheochromocytoma and initiated α-blockers without conducting a catecholamine report, leading to stable hemodynamics. We present a successfully managed case of pheochromocytoma concomitant with COVID-19, which has become a global crisis.

Download full-text PDF

Source
http://dx.doi.org/10.1507/endocrj.EJ22-0446DOI Listing

Publication Analysis

Top Keywords

severe coronavirus
8
coronavirus disease
8
disease 2019
8
2019 covid-19
8
pheochromocytoma
5
successful diagnosis
4
diagnosis treatment
4
treatment pheochromocytoma
4
pheochromocytoma severe
4
covid-19 case
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!